Efficacy News and Research

RSS

Chicoric acid a potential candidate for COVID-19 treatment

An article under review in the Scientific Reports journal and currently available on the Research Square* preprint server reports on chicoric acid (CA) as a potential inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Jul 2022

COVID-19 impairs the insulin/IGF signaling pathway

Scientists evaluate the impact of SARS-CoV-2 on the insulin/IGF signaling pathway.

6 Jul 2022

Individuals under 65 years may be the predominant drivers of COVID-19 in West Africa

Researchers evaluated the effects of age structure and vaccine prioritization regarding COVID-19 in West Africa.

6 Jul 2022

COVID-19 vaccination with bacterial peptide conjugated to receptor-binding domain elicits potent immune response

In a new study, researchers assessed the efficiency of immunization with a bacterial peptide conjugated to the SARS-CoV-2 receptor-binding domain against SARS-CoV-2 infection.

6 Jul 2022

Vaccination against smallpox efficiently protects against monkeypox infection

In a new study, researchers assessed the existing information regarding monkeypox infections.

6 Jul 2022

Targeting C5a/C5aR1 signaling ameliorates COVID-19 immunopathology

A new study investigated the role of complement component 5a (C5a) and its receptor (C5a receptor type 1, C5aR1) in the pathophysiology of COVID-19.

6 Jul 2022

Study reports how opioids cause gastric inflammation

Opioids are the gold standard for treatment of chronic and acute pain; however, their use may result in significant gastrointestinal side effects, including nausea, vomiting, and constipation.

6 Jul 2022

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

In a new study, the effectiveness of low low-density lipoprotein cholesterol levels in reducing the risk of atherosclerotic vascular events was explored.

6 Jul 2022

Evaluation of antinucleocapsid antibody seropositivity following SARS-CoV-2 infection in vaccinated individuals

A new study assessed both placebo and vaccine recipients in the mRNA-1273 (Moderna) phase 3 clinical trial who were infected with SARS-CoV-2 during the blinded, placebo-controlled trial phase.

6 Jul 2022

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

In a recent study posted to the medRxiv* pre-print server, researchers developed a mechanistic mathematical model to predict the course of vaccine-induced immunity in healthy and immunosuppressed patients for the long term, exceeding the time frames for which clinical data is currently available.

5 Jul 2022

Trial: Convalescent plasma does not improve survival or recovery in hospitalized COVID-19 patients

Convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover, according to a national clinical trial led by Vanderbilt University Medical Center and published in the journal CHEST.

5 Jul 2022

Gene defect underlying Krabbe disease causes degeneration of neurons directly, study finds

The gene defect underlying Krabbe disease causes degeneration of neurons directly, independent of its effects on other cell types, according to a new study publishing July 5th in the open-access journal PLOS Biology by Daesung Shin of the University at Buffalo, U.S. and colleagues.

5 Jul 2022

Efficacy News and Research

Chicoric acid a potential candidate for COVID-19 treatment

COVID-19 impairs the insulin/IGF signaling pathway

Individuals under 65 years may be the predominant drivers of COVID-19 in West Africa

COVID-19 vaccination with bacterial peptide conjugated to receptor-binding domain elicits potent immune response

Vaccination against smallpox efficiently protects against monkeypox infection

Targeting C5a/C5aR1 signaling ameliorates COVID-19 immunopathology

Study reports how opioids cause gastric inflammation

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

Evaluation of antinucleocapsid antibody seropositivity following SARS-CoV-2 infection in vaccinated individuals

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

Trial: Convalescent plasma does not improve survival or recovery in hospitalized COVID-19 patients

Gene defect underlying Krabbe disease causes degeneration of neurons directly, study finds

Deep RNA sequencing with molecular dynamic simulations can detect neutralizing antibodies elicited by COVID-19 patients

The dynamics of Delta and Omicron establishment and dominance in US states

The influence of immunosuppressive therapy on the development of adaptive immunity after SARS-CoV-2 vaccination

The varying patterns of acute respiratory infection hospitalizations before and during two pandemic years

Modeling the influence of COVID superspreading events

Patient-derived antibody cocktail active across SARS-CoV-2 variants of concern

Singapore researchers develop a bio-functional thermogel to prevent retinal scarring

Researchers investigate prevention and therapy against monkeypox infection

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News